499
Participants
Start Date
March 31, 2005
Primary Completion Date
June 30, 2007
Study Completion Date
July 31, 2007
EV/DNG (Qlaira, BAY86-5027, SH T00658ID)
GA: Estradiolvalerate (EV)/Dienogest (DNG) Tablet p.o. (oral) Tablet, p.o. (oral)
Clinical Research of Philadelphia, LLC, Philadelphia
Johns Hopkins Bayview Medical Center, Baltimore
Eastern Virginia Medical School, Norfolk
New Age Medical Research Corp., Miami
Comprehensive Clinical Trials, West Palm Beach
Visions Clinical Research, Palm Springs
Insignia Care for Women, P.A., Tampa
Physicians Research Group, Indianapolis
Women's Clinic of Lincoln, PC, Lincoln
Clinical Trial Center of Colorado, Castle Rock
Women and Children's Hospital, Los Angeles, Los Angeles
Harbor - UCLA Medical Center, Torrance
Genesis Center for Clinical Research, San Diego
Medical Center for Clinical Research, San Diego
Lifespan Research, Palo Alto
Oregon Health and Science University, Portland
OB/GYN Health Center, Medford
Seattle Women's: Health, Research, Gynecology, Seattle
Women's Care Source, Morristown
University of Pittsburgh Medical Center Health System, Pittsburgh
Total Concept Health Care Inc., Kitchener
Temple Green Clinic, Waterloo
Rhodin Recherche Clinique, Drummondville
Centre d'étude clinique de Montréal Inc., Montreal
Les Gynecologues Associes, Montreal
Clinique Recherche en Sante des Femmes Inc., Québec
Clinique de Gynecologie, Shawinigan
Diex Recherche Inc., Sherbrooke
Clinique Médicale des Campus, Ste-Foy
Lead Sponsor
Bayer
INDUSTRY